Increased production of serum IgA-class antibody to lipid A in Kawasaki disease

被引:9
作者
Takeshita, S
Kawase, H
Shimizu, T
Yoshida, M
Sekine, I
机构
[1] Natl Def Med Coll, Dept Pediat, Tokorozawa, Saitama 3598513, Japan
[2] Welfide Corp, Osaka, Japan
关键词
anti-lipid A IgA; Kawasaki disease; lipopolysaccharide;
D O I
10.1046/j.1442-200X.2002.01506.x
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background: The etiology of Kawasaki disease (KD) remains unknown. To investigate whether a conventional bacterial antigen is involved in the pathogenesis of KD, we studied the serum response to lipopolysaccharide (LPS). Methods: We measured the serum levels of IgG-, IgM- and IgA-class antibodies (Ab) to lipid A, a toxic site of LPS, using enzyme-linked immunosorbent assay in 20 patients with KD, 11 patients with Gram-negative bacterial infection (GNBI), 27 healthy children and 12 healthy adults. Results: The serum levels of anti-lipid A IgG, IgM and IgA tended to increase with advancing age in healthy children older than 6 months of age. The mean level of anti-lipid A IgM in the acute phase of GNBI and the mean levels of anti-lipid A IgM and IgA in the acute phase of KD were found to increase significantly, in comparison to the age-matched controls. Furthermore, the mean level of anti-lipid A IgA also showed a significant increase from the acute to the subacute phases of KD. Regarding the IgA-subclass response, higher titers of anti-lipid A specific Ab were seen in the IgA2 subclass than in the IgA1 subclass. Conclusion: These findings indicate that KD patients demonstrate an intense response to lipid A in the IgA, especially IgA2-subclass, thus suggesting that an unusual activation of the mucosal immune response to a ubiquitous antigen derived from Gram-negative bacteria may be involved in the pathogenesis of KD.
引用
收藏
页码:5 / 11
页数:7
相关论文
共 31 条
[1]   Iga multiple myeloma presenting as Henoch-Schonlein purpura polyarteritis nodosa overlap syndrome [J].
Birchmore, D ;
Sweeney, C ;
Choudhury, D ;
Konwinski, MF ;
Carnevale, K ;
DAgati, V .
ARTHRITIS AND RHEUMATISM, 1996, 39 (04) :698-703
[2]   HUMAN-ANTIBODY EFFECTOR FUNCTION [J].
BURTON, DR ;
WOOF, JM .
ADVANCES IN IMMUNOLOGY, 1992, 51 :1-+
[3]   IgA1 is the major IgA subclass in cutaneous blood vessels in Henoch-Schonlein purpura [J].
Egan, CA ;
Taylor, TB ;
Meyer, LJ ;
Petersen, MJ ;
Zone, JJ .
BRITISH JOURNAL OF DERMATOLOGY, 1999, 141 (05) :859-862
[4]   POSSIBLE POLYCLONAL B-CELL ACTIVATION IN MUCOCUTANEOUS LYMPH-NODE SYNDROME [J].
FURUKAWA, F ;
OHSHIO, G ;
HAMASHIMA, Y .
EUROPEAN JOURNAL OF PEDIATRICS, 1986, 145 (1-2) :104-108
[5]  
FURUSHO K, 1984, LANCET, V2, P1055
[6]   THE ROLE OF IGA IN LOCAL IMMUNE PROTECTION [J].
GOLDBLUM, RM .
JOURNAL OF CLINICAL IMMUNOLOGY, 1990, 10 (06) :S64-S71
[7]  
Hexham JM, 1997, CHEM IMMUNOL, V65, P73
[8]  
*JAP KAW DIS RES C, 1999, 15 NAT SURV KAW DIS
[9]  
Japan Kawasaki Disease Research Committee, 1984, DIAGN GUID KAW DIS
[10]  
KAMOI S, 1988, Japanese Journal of Gastroenterology, V85, P1245